WORCESTER, Massachusetts, Jan. 23 -- The University of Massachusetts Chan Medical School issued the following news:

* * *

UMass Chan licenses siRNA therapy to PLaN Therapeutics

Research collaboration will advance an allele-specific treatment for PLN-R14del cardiomyopathy, a rare, inherited heart disease

By Jim Fessenden

Technology developed by pioneering small interfering RNA (siRNA) chemists Anastasia Khvorova, PhD, the Remondi Fa . . .

Click here for more information about our products